Annual meeting of the Organization for the Study of Sex Differences

性别差异研究组织年会

基本信息

项目摘要

DESCRIPTION (provided by applicant): This application requests support for the Seventh Annual Meeting of the Organization for the Study of Sex Differences (OSSD), to be held April 25-27, 2013 in the greater New York City area, Weehawken NJ. The OSSD is a scientific membership society that was originally established in 2006 as an affiliate of the Society for Women's Health Research (SWHR). In July 2012, the OSSD became independently incorporated and is now under the direct control of the member scientists. The mission of the OSSD is to enhance knowledge of the biological basis of sex/gender differences in health and disease by facilitating interdisciplinary communication and collaboration among scientists and clinicians from diverse scientific and professional backgrounds. The primary goal of the OSSD annual meeting is to provide a forum for scientists to explore aspects of sex differences research at the genetic, molecular, cellular, organ, and systems levels in humans and model systems. The annual meeting consists of three independent symposia (one focused on New Investigators), ten parallel session symposia, and two poster sessions (highlighting the work of new investigators and trainees). The symposium topics for the 2013 meeting include: sex differences in treatment strategies for: epilepsy, cancer-related pain, and aged populations; sex differences in the etiology of multiple sclerosis, renal diseases, cardiac arrhythmias, heart disease, and mental illness; and the role of sex chromosome expression in disease. The Presidential Symposium will focus on Sex Differences in Autism (in conjunction with Autism Speaks), and another symposium will focus on the role of the Centers for Sex Difference Research (supported by the Office for Women's Health Research) in furthering the knowledge gained in the areas concerning sex differences in health and disease . The OSSD Program Committee selected the symposia topics from among proposals submitted by the membership. Proposals were selected on the basis of scientific merit, relevance to the goals of the OSSD, a balance of basic and clinical speakers, and rotation of topics of interest across annual meetings. The size and format of this meeting (150-200 participants) provides an excellent opportunity for networking opportunities and interactive discussions. Funds are requested to support registration fees for invited speakers (established, junior and trainee), travel expenses for junio investigators and trainees, and expenses related to the OSSD Annual Meeting Program Book and necessary audio-visual equipment rentals and associated technical support. The annual meeting program, including speaker and poster abstracts, will be made freely available on the OSSD website. We will partner with the University of Medicine and Dentistry of New Jersey to organize this event and are requesting support from pharmaceutical and biotechnology industry, local businesses, and private donors and foundations as well (to help cover non-NIH costs).
描述(由申请人提供):本申请要求支持性别差异研究组织(OSSD)第七届年会,该会议将于2013年4月25日至27日在大纽约地区,新泽西州威霍肯举行。OSSD是一个科学会员协会,最初成立于2006年,是妇女健康研究协会(SWHR)的附属机构。2012年7月,OSSD独立成立,现在由成员科学家直接控制。科学与社会事务司的使命是通过促进来自不同科学和专业背景的科学家和临床医生之间的跨学科交流和合作,加强对健康和疾病中性别/性别差异的生物学基础的认识。OSSD年会的主要目标是为科学家提供一个论坛,探讨人类和模型系统在遗传、分子、细胞、器官和系统水平上的性别差异研究。年度会议包括三个独立的专题讨论会(一个关注新研究者),十个平行会议专题讨论会和两个海报会议(突出新研究者和实习生的工作)。2013年会议的专题讨论会主题包括:癫痫、癌症相关疼痛和老年人群治疗策略的性别差异;多发性硬化症、肾病、心律失常、心脏病和精神疾病病因的性别差异以及性染色体表达在疾病中的作用。总统专题讨论会的重点是自闭症中的性别差异(与“自闭症之声”一起),另一个专题讨论会的重点是性别差异研究中心(由妇女健康研究办公室支助)在促进在健康和疾病中的性别差异方面所取得的知识方面的作用。OSSD计划委员会从会员提交的提案中选择专题讨论会的主题。提案的选择是基于科学价值,与OSSD目标的相关性,基础和临床演讲者的平衡,以及年会感兴趣的主题轮换。本次会议的规模和形式(150-200人)为交流和互动讨论提供了绝佳的机会。所请经费用于支付特邀演讲者(资深、初级和培训生)的注册费、初级调查人员和培训生的旅费、与科学与科学执行局年度会议日程手册和必要视听设备租金及相关技术支助有关的费用。年会计划,包括演讲和海报摘要,将在OSSD网站上免费提供。我们将与新泽西医学和牙科大学合作组织这次活动,并请求制药和生物技术行业、当地企业以及私人捐助者和基金会的支持(以帮助支付非nih的费用)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kevin D. Beck其他文献

Reward and punishment-based compound cue learning and generalization in opiate dependency
  • DOI:
    10.1007/s00221-017-5046-9
  • 发表时间:
    2017-07-27
  • 期刊:
  • 影响因子:
    1.600
  • 作者:
    Justin Mahlberg;Paul Haber;Kirsten Morley;Gabrielle Weidemann;Lee Hogarth;Kevin D. Beck;Catherine E. Myers;Ahmed A. Moustafa
  • 通讯作者:
    Ahmed A. Moustafa
Choice and motor impulsivity in Veterans with mild traumatic brain injury with and without history of suicide attempt
  • DOI:
    10.1016/j.psychres.2024.116265
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Alejandro Interian;Catherine E. Myers;Lisa A. Brenner;Regan Sweeney;Terra Osterberg;Vibha Reddy;Meghan Barnhart;Lauren St. Hill;Rachael B. Miller;Kevin D. Beck;Tara P. Cominski;Chi C. Chan;Keith M. Shafritz;Marianne S. Goodman;Erin A. Hazlett
  • 通讯作者:
    Erin A. Hazlett
Biological links between traumatic brain injury and Parkinson’s disease
  • DOI:
    10.1186/s40478-020-00924-7
  • 发表时间:
    2020-04-07
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Vedad Delic;Kevin D. Beck;Kevin C. H. Pang;Bruce A. Citron
  • 通讯作者:
    Bruce A. Citron
Sex and Genotype Affect Mouse Hippocampal Gene Expression in Response to Blast-Induced Traumatic Brain Injury
  • DOI:
    10.1007/s12035-025-04879-5
  • 发表时间:
    2025-04-03
  • 期刊:
  • 影响因子:
    4.300
  • 作者:
    Kathleen E. Murray;Arun Reddy Ravula;Victoria A. Stiritz;Tara P. Cominski;Vedad Delic;Caralina Marín de Evsikova;Kakulavarapu V. Rama Rao;Namas Chandra;Kevin D. Beck;Bryan J. Pfister;Bruce A. Citron
  • 通讯作者:
    Bruce A. Citron

Kevin D. Beck的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kevin D. Beck', 18)}}的其他基金

CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk for suicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
  • 批准号:
    10515654
  • 财政年份:
    2019
  • 资助金额:
    $ 1.3万
  • 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk for suicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
  • 批准号:
    10292963
  • 财政年份:
    2019
  • 资助金额:
    $ 1.3万
  • 项目类别:
An integrated startle response, fear conditioning, and muscle tremor analysis system for rodents
啮齿类动物的综合惊吓反应、恐惧调节和肌肉震颤分析系统
  • 批准号:
    9794634
  • 财政年份:
    2019
  • 资助金额:
    $ 1.3万
  • 项目类别:
A comprehensive physiology and behavior system for homecage-based assessments
用于基于家庭笼的评估的综合生理学和行为系统
  • 批准号:
    9910014
  • 财政年份:
    2019
  • 资助金额:
    $ 1.3万
  • 项目类别:
Volatile organic compound effects on brain and behavior
挥发性有机化合物对大脑和行为的影响
  • 批准号:
    10118080
  • 财政年份:
    2018
  • 资助金额:
    $ 1.3万
  • 项目类别:
Neuroinflammation and abnormal behavior following combined chemical exposures and bacterial infection
化学品暴露和细菌感染联合后的神经炎症和异常行为
  • 批准号:
    9351123
  • 财政年份:
    2017
  • 资助金额:
    $ 1.3万
  • 项目类别:
Role for Glucose-Inhibited Orexin Neurons in Weight Regain Following Dieting
葡萄糖抑制食欲素神经元在节食后体重恢复中的作用
  • 批准号:
    9977162
  • 财政年份:
    2016
  • 资助金额:
    $ 1.3万
  • 项目类别:
Neural mechanisms of extinction-resistant avoidance behavior
抗灭绝回避行为的神经机制
  • 批准号:
    7931236
  • 财政年份:
    2010
  • 资助金额:
    $ 1.3万
  • 项目类别:
Neural mechanisms of extinction-resistant avoidance behavior
抗灭绝回避行为的神经机制
  • 批准号:
    8394591
  • 财政年份:
    2010
  • 资助金额:
    $ 1.3万
  • 项目类别:
Neural mechanisms of extinction-resistant avoidance behavior
抗灭绝回避行为的神经机制
  • 批准号:
    8195590
  • 财政年份:
    2010
  • 资助金额:
    $ 1.3万
  • 项目类别:

相似海外基金

DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
  • 批准号:
    495592
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
  • 批准号:
    23K14885
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
  • 批准号:
    10668025
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
  • 批准号:
    514892030
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
    WBP Fellowship
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
  • 批准号:
    23K09597
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
  • 批准号:
    10638497
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
  • 批准号:
    10722857
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
  • 批准号:
    10724935
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
  • 批准号:
    10727929
  • 财政年份:
    2023
  • 资助金额:
    $ 1.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了